Days Inventory is also known as Days Sales of Inventory (DSI). Valeo Pharma's Average Total Inventories for the
three
months ended in Jul. 2024 was $4.22 Mil. Valeo Pharma's Cost of Goods Sold for the
three
months ended in Jul. 2024 was $6.98 Mil.
Hence, Valeo Pharma's Days Inventory for the
three
months ended in Jul. 2024 was 55.14.
The historical rank and industry rank for Valeo Pharma's Days Inventory or its related term are showing as below:
VPHIF's Days Inventory is not ranked *
in the Drug Manufacturers industry.
Industry Median: 164.48 * Ranked among companies with meaningful Days Inventory only.
Valeo Pharma's Days Inventory
declined
from Jul. 2023 (114.59) to Jul. 2024 (55.14).
Inventory Turnover measures how fast the company turns over its inventory within a year.
Valeo Pharma's Inventory Turnover for the
three
months ended in Jul. 2024 was 1.65.
Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Valeo Pharma's Inventory-to-Revenue for the
three
months ended in Jul. 2024 was 0.46.
Valeo Pharma (OTCPK:VPHIF) Days Inventory Explanation
Days Inventory indicates the liquidity of the inventory. Generally, a lower Days Inventory is preferred as it indicates a shorter duration to clear off the inventory. An increase of the ratio may indicate the company's sales slowed. Similar ratios related to Days Inventory are:
1. Inventory Turnover measures how fast the company turns over its inventory within a year.
Valeo Pharma's Inventory Turnover for the
three
months ended in Jul. 2024 is calculated as
2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Valeo Pharma's Inventory to Revenue for the
three
months ended in Jul. 2024 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
A lot of business are seasonable. It makes more sense to compare Days Inventory from the same period in the previous year instead of from the previous quarter.
Valeo Pharma Days Inventory Related Terms
Valeo Pharma Days Inventory Historical Data
* Premium members only.
The historical data trend for Valeo Pharma's Days Inventory can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Drug Manufacturers - Specialty & Generic subindustry, Valeo Pharma's Days Inventory, along with its competitors' market caps and Days Inventory data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Valeo Pharma Days Inventory vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Valeo Pharma's Days Inventory distribution charts can be found below:
* The bar in red indicates where Valeo Pharma's Days Inventory falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Valeo Pharma (VPHIF) has a Days Inventory of 55.14 as of Jul. 2024. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Valeo Pharma and its competitors.
Is Valeo Pharma's Days Inventory too high?
Valeo Pharma's current Days Inventory is 55.14. The Drug Manufacturers industry median Days Inventory is 164.48. Valeo Pharma's value of 55.14 is 66.5% below this industry median. Overall, Valeo Pharma has a GF Score™ of 12/100, reflecting its overall financial health beyond just this single metric.
How does Valeo Pharma's Days Inventory compare to ZTS?
Valeo Pharma's Days Inventory of 55.14 can be compared against companies in the Drug Manufacturers industry. The industry median Days Inventory is 164.48. Valeo Pharma's value of 55.14 is 66.5% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Inventory for a Drug Manufacturers company?
The median Days Inventory among Drug Manufacturers companies is 164.48, based on 923 companies in the industry. Companies in the top quartile (top 25%) have a Days Inventory significantly above this median, while those in the bottom quartile fall well below. However, Days Inventory should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Valeo Pharma's current Days Inventory of 55.14 is 66.5% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Inventory mean?
A high Days Inventory can signal that a stock is expensive relative to its fundamentals. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Valeo Pharma and its competitors. For the Drug Manufacturers industry, the median Days Inventory is 164.48 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Valeo Pharma's current Days Inventory is 55.14. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Valeo Pharma stock overvalued right now?
Valeo Pharma (VPHIF) has a current Days Inventory of 55.14. The current Days Inventory is 55.14 and 66.5% below the Drug Manufacturers industry median of 164.48. Valeo Pharma's overall GF Score™ is 12/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Inventory calculated?
Days Inventory is calculated from a company's financial statements. For Valeo Pharma (VPHIF), the current Days Inventory is 55.14 as of Jul. 2024. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Valeo Pharma Inc is a Canadian specialty pharmaceutical company focused on acquiring either through acquisitions, in-licensing, or similar arrangements. The company operates in two divisions: Branded prescription products and hospital specialty products. Its product portfolio includes medicines for Respiratory/Allergy, Ophthalmology, Neurology, and Oncology.
12GF Score
Get the complete analysis for VPHIF
Days Inventory is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
VPHIF has been successfully added to your 
